Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection

被引:130
作者
Shimada, Hideaki | [1 ]
Okazumi, Shin-Ichi [1 ]
Matsubara, Hisahiro [1 ]
Nabeya, Yoshihiro [1 ]
Shiratori, Tooru [1 ]
Shimizu, Takanori [1 ]
Shuto, Kiyohiko [1 ]
Hayashi, Hideki [1 ]
Ochiai, Takenori [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba 2608677, Japan
关键词
D O I
10.1007/s00268-005-0462-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Subtotal esophagectomy with three-field lymph node dissection (3FLD) has been reported to improve survival in patients with thoracic esophageal squamous cell carcinoma (SCC). The purpose of this study was to evaluate the prognostic impact of the extent and number of positive lymph nodes for long-term survival of patients who underwent 3FLD. Methods: From January 1983 to December 2002, a total of 200 patients with thoracic esophageal SCC underwent 3FLD without any neoadjuvant therapy. The prognostic impact of the extent and number of positive lymph nodes was evaluated by both univariate and multivariate analysis. Results: The extent of positive nodes associated with a 5-year survival were as follows: none, 69%; one-field, 50%; two-field, 29%; and three-field, 11%. The number of positive nodes associated with 5-year survival were as follows: single node, 65%; two-nodes, 51%; and more than three-nodes, 20%. Among patients with cervical lymphatic spreading, patients with upper tumors showed significantly better survival than patients with lower tumors (P = 0.036). Multivariate analysis indicated that number of positive nodes and the abdominal node status were independent prognostic factors among lymph node status. Conclusions: Together, number and extent of positive lymph nodes can be considered an independent predictor of a high risk of recurrence. Although cervical lymphatic spreading was risk factor for worse survival, patients with upper tumors may have survival benefit after cervical lymph node dissection.
引用
收藏
页码:1441 / 1449
页数:9
相关论文
共 18 条
[1]   RADICAL LYMPH-NODE DISSECTION FOR CANCER OF THE THORACIC ESOPHAGUS [J].
AKIYAMA, H ;
TSURUMARU, M ;
UDAGAWA, H ;
KAJIYAMA, Y .
ANNALS OF SURGERY, 1994, 220 (03) :364-373
[2]   Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus [J].
Altorki, N ;
Kent, M ;
Ferrara, C ;
Port, J .
ANNALS OF SURGERY, 2002, 236 (02) :177-183
[3]   Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years [J].
Ando, N ;
Ozawa, S ;
Kitagawa, Y ;
Shinozawa, Y ;
Kitajima, M .
ANNALS OF SURGERY, 2000, 232 (02) :225-232
[4]  
ANDO N, 2003, J CLIN ONCOL, V24, P4592
[5]  
[Anonymous], 2004, ESOPHAGUS-TOKYO, DOI DOI 10.1007/S10388-004-0014-4
[6]   LONG-TERM RESULTS OF SUBTOTAL ESOPHAGECTOMY WITH 3-FIELD LYMPHADENECTOMY FOR CARCINOMA OF THE THORACIC ESOPHAGUS [J].
BABA, M ;
AIKOU, T ;
YOSHINAKA, H ;
NATSUGOE, S ;
FUKUMOTO, T ;
SHIMAZU, H ;
AKAZAWA, K .
ANNALS OF SURGERY, 1994, 219 (03) :310-316
[7]   Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus [J].
Bhansali, MS ;
Fujita, H ;
Kakegawa, T ;
Yamana, H ;
Ono, T ;
Hikita, S ;
Toh, Y ;
Fujii, T ;
Tou, U ;
Shirouzu, K .
WORLD JOURNAL OF SURGERY, 1997, 21 (03) :275-281
[8]   Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection [J].
Igaki, H ;
Kato, H ;
Tachimori, Y ;
Nakanishi, Y .
SURGERY, 2003, 133 (04) :368-374
[9]   THE TREATMENT OF LYMPH-NODE METASTASIS FROM ESOPHAGEAL CANCER BY EXTENSIVE LYMPHADENECTOMY [J].
ISONO, K ;
OCHIAI, T ;
OKUYAMA, K ;
ONODA, S .
JAPANESE JOURNAL OF SURGERY, 1990, 20 (02) :151-157
[10]  
ISONO K, 1982, CANCER, V49, P2173, DOI 10.1002/1097-0142(19820515)49:10<2173::AID-CNCR2820491032>3.0.CO